Literature DB >> 2457268

Cutaneous histoplasmosis in the acquired immune deficiency syndrome--a report of three cases from Trinidad.

E N Barton1, L Roberts, W E Ince, A L Patrick, M Suite, K Basdayemaharaj, N Jankey, F Cleghorn, C Bartholomew.   

Abstract

Three cases are reported of patients with the Acquired Immune Deficiency Syndrome (AIDS) and cutaneous histoplasmosis. Their initial presentation was that of a generalised maculopapular rash. Two patients were bisexual males and the third was an unmarried female. The range of opportunistic infections seen in AIDS patients in Trinidad is mentioned and clinicians are alerted to the fact that in areas endemic for Histoplasma capsulatum maculopapular rash in patients with AIDS may suggest disseminated histoplasmosis. The value of skin biopsy is mentioned.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457268

Source DB:  PubMed          Journal:  Trop Geogr Med        ISSN: 0041-3232


  5 in total

1.  Histoplasma and hepatosplenomegaly.

Authors:  H Daisley
Journal:  Ann Hematol       Date:  1994-01       Impact factor: 3.673

Review 2.  Tropical respiratory medicine. 3. Histoplasmosis and pulmonary involvement in the tropics.

Authors:  S Houston
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

3.  Updated estimated incidence and prevalence of serious fungal infections in Trinidad and Tobago.

Authors:  Robert Jeffrey Edwards; Gregory Boyce; Ana Alastruey-Izquierdo; David W Denning
Journal:  IJID Reg       Date:  2021-09-27

Review 4.  Endemic mycoses in AIDS: a clinical review.

Authors:  J Wheat
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

5.  Two specific strains of Histoplasma capsulatum causing mucocutaneous manifestations of histoplasmosis: preliminary analysis of a frequent manifestation of histoplasmosis in southern Brazil.

Authors:  Luciano Z Goldani; Valério R Aquino; Luciano W Lunardi; Vanessa S Cunha; Rodrigo P Santos
Journal:  Mycopathologia       Date:  2008-12-27       Impact factor: 2.574

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.